Existing investors, the Steele Foundation for Hope and Dräger, led the financing. The company plans to use funds to accelerate the deployment of its Anne One monitoring platform. Anne One includes advanced wearable sensors, AI-enabled data analytics, and an integrated mobile software and cloud platform. It delivers wireless monitoring for all vital signs for patients 12 years and older.

The Steele Foundation for Hope previously led Sibel’s Series B round in 2022 and added a new $20 million investment. Dräger, which led the company’s Series A round, contributed $10 million more in funding.